SCHEMBL31448488

SCHEMBL31448488

O=[N+]([O-])c1c(Br)cccc1C(O)c1ccccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PMM2 O15305 1/20 0.38
MPI P34949 1/20 0.38
PDE7A Q13946 4/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
CYP1A2 P05177 1/20 0.34
PDE7B Q9NP56 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
IGFBP3 P17936 1/20 0.33
ACP3 P15309 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31448586 0.85 PMM2 (0.34) PMM2MPIPDE7AGRIN2DGRIN3B
SCHEMBL14744549 0.77 PDE7A (0.46) PDE7ACYP1A2ALDH1A1LMNAMAPT
SCHEMBL30542587 0.77 PMM2 (0.47) PMM2MPIPDE7AGRIN2DGRIN3B
SCHEMBL16397274 0.77 PMM2 (0.47) PMM2MPIPDE7AGRIN2DGRIN3B
SCHEMBL28925124 0.74 TDP1 (0.41) PMM2MPIPDE7AGRIN2DGRIN3B
SCHEMBL14831248 0.73 ADRB2 (0.36) LMNAMAPTMAPK1IGFBP3ACP3
SCHEMBL31448425 0.73 AOC3 (0.42) CYP1A2IGFBP3ACP3
SCHEMBL29976363 0.73 ADRB2 (0.48) ALDH1A1LMNAMAPTMAPK1IGFBP3
SCHEMBL230382 0.73 ADRB2 (0.48) ALDH1A1LMNAMAPTMAPK1IGFBP3
SCHEMBL27837254 0.73 TDP1 (0.44) PMM2MPICYP1A2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2025-11-27 US disclosed
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND TSHR, TRHR, GHSR PMM2 4486/4885MPI 4707/4885PDE7A 537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.